American Healthcare REIT Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
In the last three months, 5 analysts have published ratings on American Healthcare REIT (NYSE:AHR), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 3 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for American Healthcare REIT, presenting an average target of $40.4, a high estimate of $45.00, and a low estimate of $37.00. This current average has increased by 17.68% from the previous average price target of $34.33.
Interpreting Analyst Ratings: A Closer Look
The perception of American Healthcare REIT by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Nicholas Yulico | Scotiabank | Announces | Sector Outperform | $42.00 | - |
| Austin Wurschmidt | Keybanc | Raises | Overweight | $40.00 | $34.00 |
| Michael Lewis | Truist Securities | Raises | Buy | $38.00 | $32.00 |
| Ronald Kamdem | Morgan Stanley | Raises | Overweight | $45.00 | $37.00 |
| Joe Dickstein | Jefferies | Announces | Buy | $37.00 | - |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to American Healthcare REIT. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of American Healthcare REIT compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for American Healthcare REIT's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of American Healthcare REIT's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on American Healthcare REIT analyst ratings.
Discovering American Healthcare REIT: A Closer Look
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
Financial Insights: American Healthcare REIT
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: American Healthcare REIT displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 8.22%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -1.26%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -0.3%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): American Healthcare REIT's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.15%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.81, American Healthcare REIT adopts a prudent financial strategy, indicating a balanced approach to debt management.
Analyst Ratings: Simplified
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.